Latest filing published 06 Oct 2026 for 비보존 제약. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 비보존홀딩스 in 비보존 제약. Over a trading history stretching from 19 February 2021 to 6 October 2026, the count stands at 46 filings.
Market trades split into 25 purchases (€967k) and 6 sales (€314k). The totals exclude 28 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 4 purchases and 4 sales.
Clusters matter here: 2 out of 24 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 6 October 2026, reports a transaction in 비보존 제약. The most recent open-market purchase was published on 12 March 2026, 220 days ago. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 46 declarations